Ireland
--:--IST
Latest
Clinical Trials in Italy / NCT06838130
Enrolling by invitation Observational

AI-Enhanced Analysis of Breast Density and Background Parenchymal Enhancement (BPE)

NCT06838130 · tracked via the Priya Life Science Italy tracker
Sponsor
Link Campus University
Phase
Observational
Started
2022-05-01
Last updated
2025-02-20

Condition(s) studied

Breast Parenchimal EnhancementArtificial Intelligence (AI)

Study summary

This study expands upon previous research investigating the correlation between breast density, Background Parenchymal Enhancement (BPE), and age in contrast-enhanced mammography (CEM). By integrating Artificial Intelligence (AI) methodologies, including Artificial Neural Networks (ANNs) and deep learning models, the study aims to optimize the accuracy of predictions and validate prior findings obtained through multiple linear regression.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Patients who underwent CEM, mammography, and ultrasound between May 2022 and June 2023. Availability of BPE assessment, BI-RADS density classification, and age data. Complete dataset available for statistical and AI-based analysis. Exclusion Criteria: Patients with prior breast cancer treatment that could alter BPE. Incomplete imaging or missing classification data. Contraindications to contrast-enhanced imaging.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Campania Luigi Vanvitelli Naples Italy

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06838130 on ClinicalTrials.gov ↗ ← All trials in Italy